معرفی
Professor Ian Adcock is the Professor of Respiratory Cell & Molecular Biology and Head of the Molecular Cell Biology Group at the National Heart & Lung Institute, Imperial College London. He holds an honorary research position at the Royal Brompton Hospital, enabling clinical translation of his work. His academic journey includes a Biochemistry & Physiology degree from the University of London and a PhD in Pharmacology from St Thomas's Hospital, followed by postdoctoral training at MRC Brain Metabolism Unit and St George's Hospital.
Research focuses on asthma, COPD, and steroid insensitivity mechanisms. Key areas include corticosteroid resistance, airway inflammation, and translational therapies. He leads the ERS Airway Pharmacology and Treatment Section and chairs the MRC/Asthma UK Centre in Allergic Mechanisms of Asthma. His work integrates multi-omics data, AI frameworks, and international collaborations through consortia like UBIOPRED and COPD-iNET.
- Affiliations: Centre for Advanced Therapeutics, Microbiome Network, Vascular Science Network
- Grants: MRC, Wellcome Trust, BHF, EU, Industry Collaborations
- Collaborators: Professors Peter J Barnes, Maria G Belvisi, Gianni D Angelini (Imperial College); Global network including Verona, Exeter, Paris, and Sydney
Research interests span biomarker discovery, airway epithelial biology, and metabolic pathways in chronic lung diseases. He edits major journals like Respiratory Research and advises funding bodies (MRC, NIH, NHMRC). His lab explores lung rejuvenation strategies using stem cells and organoids.
Current projects include AI-driven air pollution health prediction, mechanobiology in mucus hypersecretion, and epigenetic inhibitors in COPD.
